Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.89 USD | +1.67% | -6.58% | -19.77% |
02:58pm | Bristol Myers: presents advances in lung cancer | CF |
02/06 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
Sales 2024 * | 46.09B 3,828B | Sales 2025 * | 46.06B 3,826B | Capitalization | 83.29B 6,919B |
---|---|---|---|---|---|
Net income 2024 * | -5.41B -450B | Net income 2025 * | 10.22B 849B | EV / Sales 2024 * | 2.65 x |
Net Debt 2024 * | 39.03B 3,242B | Net Debt 2025 * | 31.68B 2,631B | EV / Sales 2025 * | 2.5 x |
P/E ratio 2024 * |
-15.6
x | P/E ratio 2025 * |
7.77
x | Employees | 34,100 |
Yield 2024 * |
5.86% | Yield 2025 * |
6.15% | Free-Float | 69.27% |
Latest transcript on Bristol-Myers Squibb Company
1 day | +1.63% | ||
1 week | -6.58% | ||
1 month | -7.99% | ||
3 months | -16.63% | ||
6 months | -43.33% | ||
Current year | -19.77% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 01/15/01 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 20/19/20 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 20/19/20 |
Peter Arduini
BRD | Director/Board Member | 59 | 01/16/01 |
Derica Rice
BRD | Director/Board Member | 59 | 01/20/01 |
Date | Price | Change |
---|---|---|
31/24/31 | 41.2 | -6.58% |
30/24/30 | 44.1 | 0.00% |
29/24/29 | 44.1 | 0.00% |
28/24/28 | 44.1 | 0.00% |
27/24/27 | 44.1 | 0.00% |
End-of-day quote Lima, May 31, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.64% | 739B | |
+32.34% | 598B | |
-5.73% | 353B | |
+17.33% | 318B | |
+3.44% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.09% | 164B |
- Stock Market
- Equities
- BMY Stock
- BMY Stock